Lung Disease
📧 Sign up to get email alerts when something new happens for Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-07-22Clinical Trial Update: Standardisation of Measurements in Exhaled Breath and Exhaled Breath Condensate.
A clinical trial update about standardising measurements in exhaled breath and exhaled breath condensate, led by Maastricht University Medic…
-
CLINICAL_TRIALS trial_result · 2011-02-03Clinical Trial Update: Propofol Versus Midazolam+Alfentanil for Sedation During Bronchoscopy: Comparison by Cutaneous Carbon Dioxide Tension [NA]
This entry reports a completed clinical trial comparing propofol to a midazolam plus alfentanil sedation regimen during bronchoscopy, with c…
-
CLINICAL_TRIALS trial_result · 2010-03-15Clinical Trial Update: PleuraSeal Post Market Study (Europe) [Phase 4]
A Phase 4 post-market study of PleuraSeal in Europe for patients undergoing pulmonary lobectomy has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Lung Allograft Rejection Gene Expression Observational (LARGO) Study
The LARGO study, an observational trial evaluating gene-expression markers for lung allograft rejection, has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-10-28Clinical Trial Update: Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) [Phase 4]
Phase 4 study evaluating immune reactivity of liquid and lyophilized Palivizumab (Synagis) formulations. Results were posted in 2008.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-02-20Clinical Trial Update: Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates [Phase 3]
Clinical trial update for a Phase 3 study evaluating whether furosemide can prevent fluid overload during neonatal red blood cell transfusio…
-
CLINICAL_TRIALS trial_result · 2006-09-04Clinical Trial Update: Cardiovascular Vulnerability to Particulate Exposure
The NIEHS-sponsored clinical trial investigating cardiovascular vulnerability to particulate exposure has completed.